Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Mar;119(2):78-83.
doi: 10.1590/s1516-31802001000200008.

The perimenopause, depressive disorders, and hormonal variability

Affiliations
Review

The perimenopause, depressive disorders, and hormonal variability

C N Soares et al. Sao Paulo Med J. 2001 Mar.

Abstract

Context: Several investigations have postulated that the perimenopause may represent a period of increased psychiatric vulnerability, particularly for mood disorders. This review characterizes the perimenopause, including biological changes, the influence of psychosocial factors and the most common clinical manifestations. Clinic-based studies and community-based surveys addressing the prevalence of depressive symptoms in perimenopausal women are critically reviewed. We also discuss the potential greater vulnerability to mood disturbance during the perimenopause in response to hormonal variability. A therapeutic algorithm for management of depressive symptoms in middle-aged perimenopausal women is also presented. The role of estrogen in the treatment of perimenopausal depressive symptoms is particularly discussed. In addition, we review the existing data regarding the potential efficacy of estrogen as an antidepressant agent (monotherapy, augmentation strategy or prophylaxis).

Design: Narrative review.

CONTEXTO:: Diversos trabalhos têm apontado a peri-menopausa como um período de maior vulnerabilidade para o surgimento de transtornos psiquiátricos, particularmente os quadros depressivos. Esse artigo revisa, primeiramente, o conceito de peri-menopausa, descrevendo suas características clínicas, alterações biológicas e aspectos psicossociais. Estudos sobre a prevalência de transtornos depressivos durante a peri-menopausa, abordando diferentes sub-populações (mulheres atendidas em serviços ginecológicos especializados, estudos populacionais transversais e longitudinais), são discutidos de forma crítica. Nesse artigo também abordamos as alterações hormonais presentes durante a transição menopausal, e o seu possível papel de "gatilho" no surgimento/exacerbação de quadros depressivos. Apresentamos um modelo de abordagem terapêutica para os quadros depressivos surgidos entre mulheres na faixa etária correspondente à peri-menopausa. O papel da terapêutica de reposição hormonal, nesses quadros, é discutido através da revisão dos estudos existentes sobre o uso de estrógenos como agente antidepressivo (monoterapia, terapêutica adjuvante ou profilaxia).

TIPO DE ESTUDO:: Revisão narrativa

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Not declared

Similar articles

Cited by

References

    1. World Health Organization . Research on the menopause in the 1990s: report of a WHO scientific group. Geneva: WHO Technical Report Series number 866; 1996. - PubMed
    1. Teede H, Burger HG. The menopausal transition. In: Studd JWW, editor. The Management of Menopause - Annual Book Review. London, England: Parthenon Publishing Group; 1998. pp. 1–12.
    1. Schmidt PJ, Roca CA, Bloch M, Rubinow DR. The perimenopause and affective disorders. Semin Reprod Endocrinol. 1997;15(1):91–100. - PubMed
    1. The North American Menopause Society Clinical challenges of perimenopause: consensus opinion of the North American Menopause Society. Menopause. 2000;7:5–13. - PubMed
    1. Treolar AE. Menstrual cyclicity and the premenopause. Maturitas. 1981;3:249–264. - PubMed